Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Growth

Add To Compare

NAV on September 18, 2020
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 296 cr
Turnover Ratio 47.61%
Expense Ratio 1.20%
Exit Load 1.00%if redeemed within
365 Days
0.00%if redeemed after 365 Days
Returns
  • 1M: 7.27%
  • 1Y: 59.25%
  • 3M: 24.88%
  • 3Y: 20.69%
  • 6M: 65.99%
  • 5Y: N/A
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Rahul Singh (Since 5 months) Meeta Shetty (Since 5 months)
ISIN INF277K019A3
Fund Family Tata
P/E Ratio 37.48
P/B Ratio 4.40
Launch Date December 28, 2015
Benchmark IISL Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs IISL Nifty Pharma TR INR

Alpha 8.82
Beta 0.68
R-Squared 85.85
Info Ratio 0.85
Tracking Err 11.17
Sortino 1.306
Sharpe 0.647
Std Dev 19.475
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 0.0%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 100.00%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet

-
Best Sector Healthcare Funds
NAME LATEST
NAV
RETURNS
1y    
FUND
ASSETS
Expense
RATIO
RISK
18.527 77.34% 876 cr 0.75% -
17.020 73.85% 1,849 cr 1.47% -
249.008 66.45% 3,653 cr 1.31% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata